Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × HER2+ Metastatic Breast Cancer × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 461 Neoplasms 363 Carcinoma, Non-Small-Cell Lung 283 Colorectal Neoplasms 248 Lung Neoplasms 213 Prostatic Neoplasms 194 Carcinoma, Hepatocellular 175 Stomach Neoplasms 145 Multiple Myeloma 128 Pancreatic Neoplasms 122 Uterine Cervical Neoplasms 116 Leukemia, Myeloid, Acute 111 Rectal Neoplasms 103 Recurrence 98 Ovarian Neoplasms 95 Squamous Cell Carcinoma of Head and Neck 86 Neoplasm Metastasis 86 Glioblastoma 79 Small Cell Lung Carcinoma 75 Head and Neck Neoplasms 75 Brain Neoplasms 75 Esophageal Neoplasms 74 Endometrial Neoplasms 69 Triple Negative Breast Neoplasms 67 Colonic Neoplasms 67 Precursor Cell Lymphoblastic Leukemia-Lymphoma 61 Glioma 61 Urinary Bladder Neoplasms 54 Melanoma 54 Motor Activity 52

Interventions

asciminib 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07136428 2025-12-19

ASCENdANT

Duke University

Phase 1/2 Not yet recruiting

HER2+ Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡